semaglutide and calcium normalizes increased cardiomyocyte transients in a rat model of high fat diet‐induced obesity - Sequeira - 2025 - ESC Heart Failure Have you plateaued on Semaglutide?

The recommended injection sites include the abdomen, thigh, and upper arm, rotating them with each dose to prevent pain, bruising, and skin thickening

It was released as a blood glucose control treatment for patients with diabetes, but it was approved for use as an obesity treatment by the US Food and Drug Administration (FDA) in 2014, as it was found to be effective for weight loss without hypoglycemia in obese people who did not have diabetes

Patients ultimately have autonomy on what they want to do

All GLP-1 receptor agonists share this warning, and understanding how tirzepatide compares to other medications in this class provides useful context